Demographics (2)
- AGE_AT_COLLECTION - Subject's age in years at time of tissue collection (phv00564889.v1.p2)
- SEX - Reported gender of subject (phv00564887.v1.p2)
Other (21)
- ANALYTE_TYPE - Analyte Type (phv00305654.v2.p2)
- ANALYTE_TYPE - Type of omics assay to be performed (phv00564895.v1.p2)
- BODY_SITE - Body site where sample was collected (phv00305653.v2.p2)
- BODY_SITE - Anatomical site at which biosample was taken (phv00564892.v1.p2)
- COLLECTION_VISIT - Study visit when the primary biosample was collected (phv00564891.v1.p2)
- COLLECTION_YEAR - Year in which primary biosample was collected (phv00564890.v1.p2)
- CONSENT - Consent group (phv00305648.v2.p2)
- Funding_Source - Project funding source (phv00420598.v2.p2)
- HISTOLOGICAL_TYPE - Cell or tissue subtype derived from the primary biosample (phv00564893.v1.p2)
- IS_TUMOR - Tumor status (phv00305655.v2.p2)
- IS_TUMOR - Tumor status of the sample (phv00564894.v1.p2)
- PRIMARY_BIOSAMPLE_TYPE - Type of primary biosample (phv00564896.v1.p2)
- SAMPLE_ID - Sample ID (phv00305652.v2.p2)
- SAMPLE_ID - TOPMed Sample Identifier (TOR ID) (phv00564888.v1.p2)
- SAMPLE_ID - De-identified Sample ID (phv00305650.v2.p2)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00420597.v2.p2)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00420601.v2.p2)
- SUBJECT_ID - De-identified Subject ID (phv00305647.v2.p2)
- SUBJECT_ID - De-identified Subject ID (phv00305649.v2.p2)
- TOPMed_Phase - TOPMed Phase (phv00420599.v2.p2)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00420600.v2.p2)